---
title: "McKesson Corporation (MCK.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MCK.US.md"
symbol: "MCK.US"
name: "McKesson Corporation"
industry: "Health Care Distributors"
datetime: "2026-05-19T17:26:03.722Z"
locales:
  - [en](https://longbridge.com/en/quote/MCK.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MCK.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MCK.US.md)
---

# McKesson Corporation (MCK.US)

## Company Overview

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care.

| Item | Detail |
|------|--------|
| Industry | Health Care Distributors |
| Exchange | US Market |
| Website | [www.mckesson.com](https://www.mckesson.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:14.000Z

**Overall: C (0.49)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 16 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 12.36% |  |
| Net Profit YoY | 44.52% |  |
| P/B Ratio | -42.94 |  |
| Dividend Ratio | 0.41% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 93274737454.47 |  |
| Revenue | 403430000000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -224.31% | E |
| Profit Margin | 1.18% | C |
| Gross Margin | 3.60% | E |
| Revenue YoY | 12.36% | B |
| Net Profit YoY | 44.52% | B |
| Total Assets YoY | 9.56% | B |
| Net Assets YoY | 50.77% | A |
| Cash Flow Margin | 129.25% | B |
| OCF YoY | 12.36% | B |
| Turnover | 5.12 | A |
| Gearing Ratio | 101.01% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - McKesson Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "12.36%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "44.52%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-42.94",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.41%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "93274737454.47",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "403430000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-224.31%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "1.18%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "3.60%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "12.36%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "44.52%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "9.56%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "50.77%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "129.25%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "12.36%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "5.12",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "101.01%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 19.59 | 1/16 | 27.56 | 26.65 | 24.96 |
| PB | -42.94 | 13/16 | - | - | - |
| PS (TTM) | 0.23 | 5/16 | 0.27 | 0.26 | 0.25 |
| Dividend Yield | 0.41% | 3/16 | 0.40% | 0.38% | 0.36% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Henry Schein (HSIC.US) | B | C | A | D | B | B |
| 02 | ZeroStack (ZSTK.US) | E | B | A | A | B | B |
| 03 | McKesson (MCK.US) | E | B | A | E | B | C |
| 04 | Cencora (COR.US) | B | B | A | E | C | C |
| 05 | Cardinal Health (CAH.US) | E | C | A | E | B | C |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-15T04:00:00.000Z

Total Analysts: **17**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 11 | 65% |
| Overweight | 4 | 24% |
| Hold | 2 | 12% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 774.18 |
| Highest Target | 1107.00 |
| Lowest Target | 860.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/MCK.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/MCK.US/norm.md)
- [Related News](https://longbridge.com/en/quote/MCK.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/MCK.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**